Las Vegas, NV -- (SBWIRE) -- 09/26/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Vical Incorporated(NASDAQ:VICL), Gogo Inc(NASDAQ:GOGO), Aastrom Biosciences Inc(NASDAQ:ASTM), Prana Biotechnology Limited (ADR)(NASDAQ:PRAN)
Vical Incorporated(NASDAQ:VICL) ended higher +1.57% and complete the day at $1.29. The total number of shares changed hands during the day was 1.39 million. After opening at $1.27, the stock hit as high as $1.31. However, it traded between $1.17 and $4.74 over the last twelve months. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
For How Long VICL will Fight for Profitability? Read This Trend Analysis report
Gogo Inc(NASDAQ:GOGO) closed yesterday at $18.46, a +2.67% increase. Around 1.34 million shares were traded, beating an-average trading volume of 1.09 million shares. The company is now valued at around $1.55 Billion. Gogo Inc. provides in-flight Internet connectivity and wireless in-cabin digital entertainment solutions in the United States and internationally.
For How Long GOGO’s Gloss will Attract Investors? Find out via this report
Aastrom Biosciences Inc(NASDAQ:ASTM) moved +0.18percent higher at $0.279 and traded between $0.28 and $0.28 after opening the day at $0.28. Its performance over the last five days remained -3.79%, which stands at -7% for a month. Going back further than one month, 1-year performance after recent close was -77.86%. Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases.
Will ASTM Continue To Move Higher? Find Out Here
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN)’s shares rose, gaining +15.47 percent to close at $4.18. The stock is up around +90% this year and +77.87% for the last 12 months. Around 1.31 million shares changed hands yesterday, higher from an-average trading volume of 1.01 million shares. Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of neurological disorders in Australia.
Why Should Investors Buy PRAN After The Recent Gain? Just Go Here and Find Out
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)